Trump Admin Requests $1.4B For Ebola Quarantine Unit, Health Security Funds, Diplomatic Efforts

Trump Admin Requests $1.4B For Ebola Quarantine Unit, Health Security Funds, Diplomatic Efforts As the Ebola crisis widens, scientists are set to test two drugs — Gilead Sciences’ antiviral drug remdesivir and MappBio’s monoclonal antibody MBP-134 — to determine whether either is an effective treatment against the disease. The clinical trials will take place in Congo. https://kffhealthnews.org/morning-breakout/outbreaks-and-health-threats-062526/